Europe Biopharmaceutical Cold Chain Third Party Logistics Market Size & Outlook

The biopharmaceutical cold chain third party logistics market in Europe is expected to reach a projected revenue of US$ 20,770.1 million by 2033. A compound annual growth rate of 11.4% is expected of Europe biopharmaceutical cold chain third party logistics market from 2025 to 2033.
Revenue, 2024 (US$M)
$7,918.7
Forecast, 2033 (US$M)
$20,770.1
CAGR, 2025 - 2033
11.4%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe biopharmaceutical cold chain third party logistics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Europe biopharmaceutical cold chain third party logistics market highlights

  • The Europe biopharmaceutical cold chain third party logistics market generated a revenue of USD 7,918.7 million in 2024.
  • The market is expected to grow at a CAGR of 11.4% from 2025 to 2033.
  • In terms of segment, transportation was the largest revenue generating service in 2024.
  • Monitoring & Visibility Solutions is the most lucrative service segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2025 to 2033.


Europe data book summary

Market revenue in 2024USD 7,918.7 million
Market revenue in 2033USD 20,770.1 million
Growth rate11.4% (CAGR from 2025 to 2033)
Largest segmentTransportation
Fastest growing segmentMonitoring & Visibility Solutions
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTransportation, Warehousing & Storage, Packaging Solutions, Monitoring & Visibility Solutions, Inventory Management
Key market players worldwideCardinal Health Inc, DHL Group, Agility, SF Express, Kinesis Medical B.V., United Parcel Service of America, Inc., Barrett Distribution, Cencora Inc, DB Schenker, FedEx Corp, Kuehne + Nagel International AG, Kerry Logistics Network Ltd., Freight Logistics Solutions


Other key industry trends

  • In terms of revenue, Europe region accounted for 25.9% of the global biopharmaceutical cold chain third party logistics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 16,476.0 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharmaceutical Cold Chain Third Party Logistics Market Companies

Name Profile # Employees HQ Website
Freight Logistics Solutions View profile - - -
Barrett Distribution View profile - - -
Kinesis Medical B.V. View profile - - -
Kerry Logistics Network Ltd. View profile - - -
United Parcel Service of America, Inc. View profile - - -
Agility View profile 10001+ Singapore, Central Region, Singapore, Asia http://www.agility.com
DB Schenker View profile 10001+ Essen, Nordrhein-Westfalen, Germany, Europe https://www.dbschenker.com/global
SF Express View profile 10001+ Shenzhen, Guangdong, China, Asia https://www.sf-cityrush.com
Cencora Inc View profile 46000 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 https://www.cencora.com
Kuehne + Nagel International AG View profile 93064 Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 http://www.kuehne-nagel.com
FedEx Corp View profile 787400 942 South Shady Grove Road, Memphis, TN, United States, 38120 https://www.fedex.com
DHL Group View profile 594396 Platz der Deutschen Post, Bonn, NW, Germany, 53250 http://www.dpdhl.com
Cardinal Health Inc View profile 48000 7000 Cardinal Place, Dublin, OH, United States, 43017 https://www.cardinalhealth.com

Europe biopharmaceutical cold chain third party logistics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical cold chain third party logistics market will help companies and investors design strategic landscapes.


Transportation was the largest segment with a revenue share of 47.55% in 2024. Horizon Databook has segmented the Europe biopharmaceutical cold chain third party logistics market based on transportation, warehousing & storage, packaging solutions, monitoring & visibility solutions, inventory management covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Europe biopharmaceutical cold chain third party logistics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe biopharmaceutical cold chain third party logistics market databook

  • Our clientele includes a mix of biopharmaceutical cold chain third party logistics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biopharmaceutical cold chain third party logistics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biopharmaceutical cold chain third party logistics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe biopharmaceutical cold chain third party logistics market size, by country, 2021-2033 (US$M)

Europe Biopharmaceutical Cold Chain Third Party Logistics Market Outlook Share, 2024 & 2033 (US$M)

Europe biopharmaceutical cold chain third party logistics market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online